CA2016999A1 - Methode et appareil d'esai - Google Patents
Methode et appareil d'esaiInfo
- Publication number
- CA2016999A1 CA2016999A1 CA 2016999 CA2016999A CA2016999A1 CA 2016999 A1 CA2016999 A1 CA 2016999A1 CA 2016999 CA2016999 CA 2016999 CA 2016999 A CA2016999 A CA 2016999A CA 2016999 A1 CA2016999 A1 CA 2016999A1
- Authority
- CA
- Canada
- Prior art keywords
- antigen
- antibody
- porous membrane
- providing
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000003556 assay Methods 0.000 title claims abstract description 18
- 239000012528 membrane Substances 0.000 claims abstract description 96
- 239000000427 antigen Substances 0.000 claims abstract description 76
- 102000036639 antigens Human genes 0.000 claims abstract description 74
- 108091007433 antigens Proteins 0.000 claims abstract description 74
- 239000002245 particle Substances 0.000 claims abstract description 38
- 239000007788 liquid Substances 0.000 claims abstract description 36
- 230000000007 visual effect Effects 0.000 claims abstract description 30
- 239000006194 liquid suspension Substances 0.000 claims abstract description 21
- 239000011859 microparticle Substances 0.000 claims abstract description 11
- 239000004793 Polystyrene Substances 0.000 claims abstract description 8
- 229920002223 polystyrene Polymers 0.000 claims abstract description 8
- 241000606161 Chlamydia Species 0.000 claims description 29
- 238000012360 testing method Methods 0.000 claims description 21
- 238000003149 assay kit Methods 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 13
- 239000011148 porous material Substances 0.000 claims description 11
- 239000002250 absorbent Substances 0.000 claims description 8
- 230000002745 absorbent Effects 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 5
- 238000003018 immunoassay Methods 0.000 claims description 4
- 239000004816 latex Substances 0.000 claims description 4
- 229920000126 latex Polymers 0.000 claims description 4
- 230000014759 maintenance of location Effects 0.000 claims description 4
- 238000005259 measurement Methods 0.000 claims description 3
- 206010018612 Gonorrhoea Diseases 0.000 claims description 2
- 208000001786 gonorrhea Diseases 0.000 claims description 2
- 239000003446 ligand Substances 0.000 claims description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims 8
- 238000000034 method Methods 0.000 abstract description 18
- 239000000523 sample Substances 0.000 description 35
- 239000000243 solution Substances 0.000 description 24
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 229940038705 chlamydia trachomatis Drugs 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- 241000606153 Chlamydia trachomatis Species 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000013504 Triton X-100 Substances 0.000 description 3
- 229920004890 Triton X-100 Polymers 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 101710105759 Major outer membrane porin Proteins 0.000 description 2
- 101710164702 Major outer membrane protein Proteins 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000001045 blue dye Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- UIQMVEYFGZJHCZ-SSTWWWIQSA-N Nalorphine Chemical compound C([C@@H](N(CC1)CC=C)[C@@H]2C=C[C@@H]3O)C4=CC=C(O)C5=C4[C@@]21[C@H]3O5 UIQMVEYFGZJHCZ-SSTWWWIQSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- QPMSXSBEVQLBIL-CZRHPSIPSA-N ac1mix0p Chemical compound C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1.O([C@H]1[C@]2(OC)C=CC34C[C@@H]2[C@](C)(O)CCC)C2=C5[C@]41CCN(C)[C@@H]3CC5=CC=C2O QPMSXSBEVQLBIL-CZRHPSIPSA-N 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000013096 assay test Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000002764 solid phase assay Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 239000003656 tris buffered saline Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/587—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Nanotechnology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38209789A | 1989-07-19 | 1989-07-19 | |
| US382,097 | 1989-07-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2016999A1 true CA2016999A1 (fr) | 1991-01-19 |
Family
ID=23507505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2016999 Abandoned CA2016999A1 (fr) | 1989-07-19 | 1990-05-17 | Methode et appareil d'esai |
Country Status (2)
| Country | Link |
|---|---|
| CA (1) | CA2016999A1 (fr) |
| WO (1) | WO1991001485A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2262986A (en) * | 1992-01-03 | 1993-07-07 | Pall Corp | Particle agglutination assay |
| WO2012107559A1 (fr) | 2011-02-11 | 2012-08-16 | Fzmb Gmbh Forschungszentrum Für Medizintechnik Und Biotechnologie | Procédé de détection de cellules à partir d'un échantillon |
| EP2807272A1 (fr) * | 2012-01-27 | 2014-12-03 | Ventana Medical Systems, Inc. | Dispositifs et procédés de détection de bio-analytes à l'aide de motifs optiquement déchiffrables |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4632901A (en) * | 1984-05-11 | 1986-12-30 | Hybritech Incorporated | Method and apparatus for immunoassays |
| CA1291031C (fr) * | 1985-12-23 | 1991-10-22 | Nikolaas C.J. De Jaeger | Methode pour la detection de liants specifiques et des substances liables par ceux-ci |
| US4920046A (en) * | 1987-02-20 | 1990-04-24 | Becton, Dickinson And Company | Process, test device, and test kit for a rapid assay having a visible readout |
| JPS63305251A (ja) * | 1987-06-05 | 1988-12-13 | Dai Ichi Pure Chem Co Ltd | ラテツクス凝集反応を利用する免疫学的測定方法 |
| US4859612A (en) * | 1987-10-07 | 1989-08-22 | Hygeia Sciences, Inc. | Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite |
-
1990
- 1990-05-17 CA CA 2016999 patent/CA2016999A1/fr not_active Abandoned
- 1990-05-30 WO PCT/US1990/003025 patent/WO1991001485A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1991001485A1 (fr) | 1991-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2628792B2 (ja) | 改良されたリガンドのアッセイ | |
| US4818677A (en) | Membrane assay using focused sample application | |
| US6057165A (en) | Quality control procedure for membrane flow-through diagnostic assay devices | |
| US4430436A (en) | Analytical element and method of use | |
| US5147780A (en) | Multiwell stat test | |
| US4851210A (en) | Blood typing device | |
| US5573919A (en) | Assay using an absorbent material | |
| GB2342443A (en) | Immunoassay device | |
| CA2003942A1 (fr) | Support pour dosage en phase solide | |
| US4716123A (en) | Solid phase biological diagnostic assay via visual observation as enhanced by Mie scattering | |
| EP0587222B1 (fr) | Eléments secs avec une couche absorbante séparée pour immunoessais | |
| ATE26187T1 (de) | Vorrichtung zum homogenen spezifischen bindungsassay, verfahren zu deren herstellung und analytisches verfahren zur anwendung der vorrichtung. | |
| CA2016999A1 (fr) | Methode et appareil d'esai | |
| JP3007410B2 (ja) | マルチウエルテスト | |
| CA2038776A1 (fr) | Essai faisant appel a un materiau absorbant | |
| CA2570383C (fr) | Dispositif de filtre, procede, kit et utilisation de celui-ci | |
| WO1994014068A1 (fr) | Procede et dispositif d'analyse concernant le vih | |
| KR910001313B1 (ko) | 면역 분석 방법 및 장치 | |
| CA1245981A (fr) | Analyse de diagnostic biologique en phase solide | |
| JPH0727765A (ja) | 吸収材料を使用するアッセイ | |
| JPH05312806A (ja) | 糞便中ヘモグロビン検出用装置 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |